New research reveals how Parkinson's spreads from the gut to the brain, with the help of immune cells – offering a new ...

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson ...

For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms ...

Parkinson's disease is degenerative neurological disorder that primarily affects movement due to damage to dopamine-producing nerve cells ...

Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in ...

Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...

After three years of study, the researchers found that alpha-synuclein, a protein closely linked to Parkinson’s disease, ...

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson's disease in its earliest stages, before extensive brain damage has ...

TRPML1 is a promising target1 for Parkinson’s disease treatments and identifying translational biomarkers will help confirm target engagement ...

Long-term cycling programs appear to reshape brain signals in Parkinson’s patients Deep brain stimulation recordings reveal neural changes after 12 sessions Findings suggest dynamic exercise may ...

Researchers from Denmark have uncovered strong evidence that depression often appears years before Parkinson’s disease and ...

Parkinson’s disease is a long-term illness that affects the brain and mainly causes problems with movement, developing slowly ...